Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-25-315863
Filing Date
2025-12-11
Accepted
2025-12-11 16:00:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10477
  Complete submission text file 0001193125-25-315863.txt   12237
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Subject) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-87811 | Film No.: 251564850
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address FORBION CAPITAL PARTNERS GOOIMEER 2-35 NAARDEN P7 1411
Business Address FORBION CAPITAL PARTNERS GOOIMEER 2-35 NAARDEN P7 1411 31 356993000
ForGrowth III PA B.V. (Filed by) CIK: 0002050902 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G